Occurrence, presentation and treatment of candidemia

Małgorzata Mikulska, Valerio Del Bono, Sandra Ratto, Claudio Viscoli

Research output: Contribution to journalArticlepeer-review


Candida is one of the most common causes of nosocomial bloodstream infections. Candidemia is not confined to hematological patients, intensive care units or abdominal surgery wards, but it is remarkably frequent in the internal medicine setting. High mortality associated with candidemia can be reduced by prompt, appropriate antifungal therapy. The epidemiology of species has been shifting toward non-albicans strains. Significant improvements in nonculture-based diagnostic methods, such as serological markers, have been made in recent years, and novel diagnostic techniques should be further studied to enable early pre-emptive therapy. Treatment guidelines indicate that echinocandins are at present the best choice for patients who are severely ill or possibly infected with fluconazole-resistant strains.

Original languageEnglish
Pages (from-to)755-765
Number of pages11
JournalExpert Review of Clinical Immunology
Issue number8
Publication statusPublished - Nov 2012


  • (1,3)-β-d-glucan
  • echinocandin
  • mannan
  • mortality
  • non-pre-emptive therapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Occurrence, presentation and treatment of candidemia'. Together they form a unique fingerprint.

Cite this